Another Loss For Pharma In 'Induce' Kickback Law Challenge

By Dan McKay · January 19, 2024, 10:57 PM EST

The pharmaceutical industry lost another round in court in recent days amid a forceful push to narrow enforcement of the Anti-Kickback Statute, leaving the status quo in place for now but...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Pharmaceutical Coalition for Patient Access v. United States of America et al.

Case Number

3:22-cv-00714

Court

Virginia Eastern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

November 09, 2022

Recent Articles By Dan

November 15, 2024
Teva Defends Mifepristone Antitrust Case Against Corcept
November 12, 2024
Wash. Ballot Win Gives States Blueprint For 'Age Wave' Care
November 06, 2024
Voters Pass Medicaid Tax In Calif., Support IVF Coverage In Ill.
November 05, 2024
Biotech, Pharma Cos. Eye Impact Of DOJ's Foreign Data Rule
October 31, 2024
Beverly Hills Agrees To Abortion-Rights Training In Settlement
October 29, 2024
4th Circ. Quizzes Drugmaker Challenging W.Va. Abortion Law
October 29, 2024
Beyond Abortion, 7 Ballot Questions Set To Shape Care
October 23, 2024
NC Justices Scrutinize Scope Of Liability Shield In COVID Law
October 22, 2024
Drug-Shortage List Under Scrutiny After FDA Reversal
October 15, 2024
Citing Jarkesy, E-Cig Store Seeks To Vaporize FDA Penalties